Literature DB >> 1084863

Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. I. Monocyte is the reactive cell.

N Grosser, J H Marti, J W Proctor, D M Thomson.   

Abstract

Peripheral blood leukocytes (PBL) from breast cancer patients with early or localized cancer fail to adhere to glass in the presence of breast cancer extract. The same leukocytes do not react to unrelated tumour extracts. Enrichment and depletion of certain PBL populations from patients with apparently localized breast cancer indicated that the indicator and/or reactive cell manifesting non-adherence in the presence of appropriate tumour antigen was phagocytic, glass adherent in the absence of tumour antigen and had cell surface Fc-receptors. The cell involved, therefore, appears to be the circulating monocyte. These results show that in the tube LAI assay, the peripheral blood monocyte appears to react directly with the tumour antigen resulting in a loss of its property of adherence to glass.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084863     DOI: 10.1002/ijc.2910180107

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.

Authors:  T J Yang; T J Palker; M W Harding
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).

Authors:  M W Harding; T J Yang
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy.

Authors:  J R Wall; B A Walters; C Grant
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

4.  Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.

Authors:  G Shenouda; D M Thomson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Authors:  M L Apuzzo; K M Sheikh; M H Weiss; J S Heiden; T Kurze
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

Review 6.  The mechanisms by which polyamines accelerate tumor spread.

Authors:  Kuniyasu Soda
Journal:  J Exp Clin Cancer Res       Date:  2011-10-11

7.  Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumour-specific gamma-globulin.

Authors:  D M Thomson; D N Tataryn; R Schwartz
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

8.  The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.

Authors:  M Lopez; R O'Connor; J K MacFarlane; D M Thomson
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

9.  Isolation of human tumour-specific antigens associated with beta2 microglobulin.

Authors:  D M Thomson; J E Rauch; J C Weatherhead; P Friedlander; R O'Connor; N Grosser; J Shuster; P Gold
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.